Creative Planning
HITK

Creative Planning’s HI-TECH PHARMACAL INC HITK Stock Holding History

Creative Planning’s Portfolio HITK Stock Details HITK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-500
Closed -$22K – 3647
2013
Q3 		$22K Buy
+500
New +$19.1K ﹤0.01% 2055

Other funds holding HITK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
LIM
Longfellow Investment Management Boston, Massachusetts $489M AUM 9.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Creative Planning's HITK Position: Q4 2013 in Review

Creative Planning sold out of HI-TECH PHARMACAL INC (HITK) in Q4 2013, closing a stake of 500 shares — an estimated $22K sold.

Creative Planning first reported a position in HITK in Q3 2013 and held it in 1 quarter. The position peaked at $22K in Q3 2013. 101 funds tracked by Wall St. Rank hold HITK as of Q4 2013.

  • Creative Planning reported no remaining HI-TECH PHARMACAL INC position as of Q4 2013 after selling out during the quarter.
  • Creative Planning sold 500 HI-TECH PHARMACAL INC shares in Q4 2013, an estimated $22K.
  • Creative Planning first reported a position in HI-TECH PHARMACAL INC in Q3 2013 and held it in 1 quarter.
  • Creative Planning's HI-TECH PHARMACAL INC position peaked at $22K in Q3 2013.
  • 101 funds tracked by Wall St. Rank held HI-TECH PHARMACAL INC as of Q4 2013.

Based on Creative Planning's 13F filing for Q4 2013, filed 6 Jan 2014.